Clinical Focus on Dysregulation

Application of BrSM in clinical practice focuses on identifying dysregulated autoregulatory networks.

In diseases where a stressor and a dysregulated network are engaged in a perpetuating cycle (such as the case of the immune system in allergic asthma, for example), all blocks to autoregulation must be addressed in order to recover regulation. When treating conditions of severe regulation rigidity without adequate and timely restoration of regulation, a more comprehensive treatment program is necessary to remove all stressors and blocks to auto-regulation/compensation, and to apply the appropriate courses of bioregulating medicines. Regulation may take months or even several seasons to achieve.

  • Application of BrSM in clinical practice focuses on the identification of dysregulated autoregulatory networks.

Diseases that share common networks and often manifest together may be treated comprehensively, not only symptomatically. From system biology perspective, perturbed networks collectively offer a clear picture of dysregulation. Treatment that addresses the perturbed networks can restore regulation and relieve the syndrome.

Treatment is also possible in the absence of clinical symptomatology in order to optimize the autoregulatory system. In the future, diagnostic methods that assess the status of the autoregulatory system will help to define this point of optimization, and allow for preventive treatment through medications with bioregulatory properties.

When certain diseases reach the point at which autoregulation is impossible to restore, BrSM can still be used to treat symptoms and prevent further complications. BrSM can provide effective and safe relief of symptoms and prevent cascade iatrogenesis. In severe conditions, BrSM may provide an adjuvant treatment to conventional treatment.